title: Titrating clozapine amidst recommendations proposing high myocarditis risk and rapid titrations.
authors: University of Kentucky Mental Health Research Center at Eastern State Hospital, Lexington, KY, USA. jdeleon@uky.edu.|Psychiatry and Neurosciences Research Group (CTS-549), Institute of Neurosciences, University of Granada, Granada, Spain. jdeleon@uky.edu.|Biomedical Research Centre in Mental Health Net (CIBERSAM), Santiago Apóstol Hospital, University of the Basque Country, Vitoria, Spain. jdeleon@uky.edu.
authors: J
authors: J
authors: de Leon
authors: Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.|Beijing Key Laboratory of Mental Disorders, Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing, China.
authors: Y-L
authors: YL
authors: Tang
authors: Department of Physiology, Los Andes University Medical School, Mérida, Venezuela.
authors: T
authors: T
authors: Baptista
authors: Dutch Clozapine Collaboration Group, Castricum, The Netherlands.|FACT-team in Heerhugowaard, Department of Severe Mental Illness, Mental Health Services North-Holland North, Alkmaar, The Netherlands.
authors: D
authors: D
authors: Cohen
authors: Dutch Clozapine Collaboration Group, Castricum, The Netherlands.|Specialized Treatment Division, Mental Health Services North-Holland North, Alkmaar, the Netherlands.
authors: P F J
authors: PF
authors: Schulte
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects*; D003024:Clozapine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D009205:Myocarditis / Q000139:chemically induced*
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine